107 related articles for article (PubMed ID: 2646533)
1. Influence of the Uvr repair system on the mutagenicity of antiparasitic drugs.
Espinosa-Aguirre JJ; Ramírez Santos J; Cortinas de Nava C
Mutat Res; 1989 Mar; 222(3):161-6. PubMed ID: 2646533
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity of antiamebic and anthelmintic drugs in the Salmonella typhimurium microsomal test system.
Cortinas de Nava C; Espinosa J; García L; Zapata AM; Martínez E
Mutat Res; 1983 Apr; 117(1-2):79-91. PubMed ID: 6339911
[TBL] [Abstract][Full Text] [Related]
3. The detection of chemical impurities by high pressure liquid chromatography and the genetic activity of medical grades of pyrvinium pamoate in Saccharomyces cerevisiae and Salmonella typhimurium.
Hennig UG; Chatten LG; Pon RA; von Borstel RC
Arch Toxicol; 1987 Jun; 60(4):278-86. PubMed ID: 3307704
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of amebicide and anthelmintic drugs in Escherichia coli pol A+/pol A-.
Espinosa-Aguirre JJ; Aroumir C; Meza MT; Cienfuegos E; Cortinas de Nava C
Mutat Res; 1987 Jun; 188(2):111-20. PubMed ID: 2884563
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of chlordimeform and degradation products for mutagenic and DNA-damaging activity in Salmonella typhimurium and Escherichia coli.
Rashid KA; Ercegovich CD; Mumma RO
J Environ Sci Health B; 1984 Feb; 19(1):95-110. PubMed ID: 6371114
[TBL] [Abstract][Full Text] [Related]
6. Pyrvinium pamoate lacks in vivo genotoxicity in the colon.
Goldberg MT
Toxicol Appl Pharmacol; 1984 Jun; 74(2):293-5. PubMed ID: 6740678
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. I. Monosubstituted derivatives of 9H-carbazole.
André V; Boissart C; Lechevrel M; Gauduchon P; Le Talaër JY; Lancelot JC; Letois B; Saturnino C; Rault S; Robba M
Mutat Res; 1993 Mar; 299(1):63-73. PubMed ID: 7679194
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic activity of 2-chloro-4-nitroaniline and 5-chlorosalicylic acid in Salmonella typhimurium: two possible metabolites of niclosamide.
Espinosa-Aguirre JJ; Reyes RE; Cortinas de Nava C
Mutat Res; 1991 Nov; 264(3):139-45. PubMed ID: 1944396
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the genetic activity of pyrvinium pamoate with that of several other anthelmintic drugs in Saccharomyces cerevisiae.
Hennig UG; Galindo-Prince OC; Cortinas de Nava C; Savage EA; von Borstel RC
Mutat Res; 1987 Feb; 187(2):79-89. PubMed ID: 3543669
[TBL] [Abstract][Full Text] [Related]
10. The comparative responses of Salmonella typhimurium TA1537 and TA97a to a range of reference mutagens and novel compounds.
O'Donovan MR
Mutagenesis; 1990 May; 5(3):267-74. PubMed ID: 2200947
[TBL] [Abstract][Full Text] [Related]
11. Optimum associations of tester strains for maximum detection of mutagenic compounds in the Ames test.
Bonneau D; Thybaud V; Melcion C; Bouhet F; Cordier A
Mutat Res; 1991 Jun; 252(3):269-79. PubMed ID: 2052007
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of the gene encoding the classical nitroreductase enzyme in Salmonella typhimurium Ames test strains TA1535 and TA1538.
Yamada M; Espinosa-Aguirre JJ; Watanabe M; Matsui K; Sofuni T; Nohmi T
Mutat Res; 1997 Apr; 375(1):9-17. PubMed ID: 9129675
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity tests on anthelmintics: microsomal activation of viprynium embonate to a mutagen.
Macphee DG; Podger DM
Mutat Res; 1977 Jul; 48(3-4):307-12. PubMed ID: 327314
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity of substituted carbazoles in Salmonella typhimurium.
LaVoie EJ; Briggs G; Bedenko V; Hoffmann D
Mutat Res; 1982 Apr; 101(2):141-50. PubMed ID: 7048081
[TBL] [Abstract][Full Text] [Related]
15. Bacterial mutagenic evaluation of Luxabendazole, a new broad spectrum anthelmintic, with the Salmonella typhimurium His- and the Escherichia coli Tryp- reversion tests.
Ortiz AI; Pollastrini MT; Barea M; Ordóñez D
Mutagenesis; 1996 Jan; 11(1):27-31. PubMed ID: 8671711
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
Araki A; Kamigaito N; Sasaki T; Matsushima T
Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
[TBL] [Abstract][Full Text] [Related]
17. Genetic toxicology studies with 2-nitrobenzofurans and 2-nitronaphthofurans.
Weill-Thevenet N; Buisson JP; Royer R; Hofnung M
Mutat Res; 1982 Apr; 104(1-3):1-8. PubMed ID: 7043249
[TBL] [Abstract][Full Text] [Related]
18. Organogermanium compounds as inhibitors of the activity of direct acting mutagens in Salmonella typhimurium.
Schimmer O; Eschelbach H; Breitinger DK; Grützner T; Wick H
Arzneimittelforschung; 1997 Dec; 47(12):1398-402. PubMed ID: 9450171
[TBL] [Abstract][Full Text] [Related]
19. Bacterial mutagens in the urine of patients under tinidazole treatment.
Espinosa-Aguirre JJ; de la Torre RA; Lares-Asseff I; Rubino J; Dorado V; Wong M; Hernández JM
Mutat Res; 1996 Feb; 359(2):133-40. PubMed ID: 8598831
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of (p-nitrophenyl)adenines in Salmonella typhimurium.
Matsuda A; Akashi M; Ohara Y; Wataya Y; Hayatsu H; Ueda T
Mutat Res; 1991 Jun; 263(2):93-100. PubMed ID: 2046707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
